Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance

Citation
Oa. Santos-filho et al., Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance, BIOPHYS CH, 91(3), 2001, pp. 305-317
Citations number
64
Categorie Soggetti
Biochemistry & Biophysics","Physical Chemistry/Chemical Physics
Journal title
BIOPHYSICAL CHEMISTRY
ISSN journal
03014622 → ACNP
Volume
91
Issue
3
Year of publication
2001
Pages
305 - 317
Database
ISI
SICI code
0301-4622(20010724)91:3<305:HMOWTA>2.0.ZU;2-J
Abstract
We propose a low-resolution model for both the wild type and the pyrimetham ine (Pyr)/cycloguanil (Cyc) cross- resistant mutant type Plasmodium falcipa rum DHFR (PfDHFR), based on homology modeling using chicken liver DHFR as a template. The built models contain five alpha -helices. eight beta -sheets , eight tight turns and several loops. The Ramachandran plot for the models shows 95.3 and 100% of the amino acid residues in the favorable regions fo r the whole enzymes and for the active sites, respectively. Furthermore, we made a preliminary analysis of the complexes Pyr/Cyc-wild DHFR and Pyr/Cyc -mutant DHFR in order to explain the probable mechanism of resistance. Our results show that the steric factor may be the main structural cause of P. falciparum resistance toward antifolate drugs. (C) 2001 Published by Elsevi er Science B.V.